A detailed history of Orbimed Advisors LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 11,024,000 shares of LXRX stock, worth $10.8 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
11,024,000
Previous 5,846,100 88.57%
Holding current value
$10.8 Million
Previous $9.82 Million 76.22%
% of portfolio
0.41%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.51 - $2.39 $7.82 Million - $12.4 Million
5,177,900 Added 88.57%
11,024,000 $17.3 Million
Q2 2024

Aug 14, 2024

BUY
$1.54 - $2.28 $3.55 Million - $5.25 Million
2,304,100 Added 65.05%
5,846,100 $9.82 Million
Q1 2024

May 15, 2024

BUY
$1.3 - $3.58 $4.6 Million - $12.7 Million
3,542,000 New
3,542,000 $8.5 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $185M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.